Authors,Author(s) ID,Title,Year,Source tittle,Cited by,DOI,Country,Document Type,City,Access Type,aggregationType,EID
El-Serag H.,,Visceral abdominal obesity measured by CT scan is associated with an increased risk of Barrett's oesophagus: A case-control study,2014,Gut,64,10.1136/gutjnl-2012-304189,United States;United States,Article,Houston;Houston,0,Journal,2-s2.0-84891744328
Bulsiewicz W.,,Safety and efficacy of endoscopic mucosal therapy with radiofrequency ablation for patients with neoplastic barrett's esophagus,2013,Clinical Gastroenterology and Hepatology,76,10.1016/j.cgh.2012.10.028,United States,Article,Chapel Hill,0,Journal,2-s2.0-84878116554
Johnson D.,,Reported Side Effects and Complications of Long-term Proton Pump Inhibitor Use: Dissecting the Evidence,2013,Clinical Gastroenterology and Hepatology,75,10.1016/j.cgh.2012.11.031,United States,Article,Norfolk,0,Journal,2-s2.0-84876727294
Richter J.,,Gastroesophageal Reflux Disease Treatment: Side Effects and Complications of Fundoplication,2013,Clinical Gastroenterology and Hepatology,93,10.1016/j.cgh.2012.12.006,United States,Article,Tampa,0,Journal,2-s2.0-84876709288
Lo W.,,Proton Pump Inhibitor Use and the Risk of Small Intestinal Bacterial Overgrowth: A Meta-analysis,2013,Clinical Gastroenterology and Hepatology,163,10.1016/j.cgh.2012.12.011,United States;United States,Review,Boston;,0,Journal,2-s2.0-84876711968
Fraser L.,,The effect of proton pump inhibitors on fracture risk: Report from the Canadian Multicenter Osteoporosis Study,2013,Osteoporosis International,86,10.1007/s00198-012-2112-9,Canada;Canada,Article,London;London,0,Journal,2-s2.0-84876466976
Kastelein F.,,Proton pump inhibitors reduce the risk of neoplastic progression in patients with barrett's esophagus,2013,Clinical Gastroenterology and Hepatology,124,10.1016/j.cgh.2012.11.014,Netherlands,Article,Rotterdam,0,Journal,2-s2.0-84875365855
Dunn S.P.,,Impact of proton pump inhibitor therapy on the efficacy of clopidogrel in the CAPRIE and CREDO trials.,2013,Journal of the American Heart Association,37,10.1161/JAHA.112.004564,United States,Article,Charlottesville,1,,2-s2.0-84881460788
Deshpande A.,,Acid-suppressive therapy is associated with spontaneous bacterial peritonitis in cirrhotic patients: A meta-analysis,2013,Journal of Gastroenterology and Hepatology (Australia),99,10.1111/jgh.12065,United States,Article,Cleveland,0,Journal,2-s2.0-84872793547
Katz P.O.,,Guidelines for the diagnosis and management of gastroesophageal reflux disease,2013,American Journal of Gastroenterology,843,10.1038/ajg.2012.444,United States,Article,Philadelphia,0,Journal,2-s2.0-84875225548
Evans J.A.,,The role of endoscopy in Barrett's esophagus and other premalignant conditions of the esophagus,2012,Gastrointestinal Endoscopy,236,10.1016/j.gie.2012.08.004,,Article,,0,Journal,2-s2.0-84869199932
Spechler S.,,Barrett's Esophagus: Is the Goblet Half Empty?,2012,Clinical Gastroenterology and Hepatology,12,10.1016/j.cgh.2012.08.015,United States,Editorial,Dallas,0,Journal,2-s2.0-84867710464
De Jager C.,,Proton pump inhibitor therapy predisposes to community-acquired Streptococcus pneumoniae pneumonia,2012,Alimentary Pharmacology and Therapeutics,52,10.1111/apt.12069,Netherlands,Article,'s-Hertogenbosch,1,Journal,2-s2.0-84867580185
Burke Z.,,Barrett's metaplasia as a paradigm for understanding the development of cancer,2012,Current Opinion in Genetics and Development,23,10.1016/j.gde.2012.08.001,United Kingdom,Review,Bath,0,Journal,2-s2.0-84868204925
Tejani M.A.,,Multi-modality therapy for cancer of the esophagus and GE junction,2012,Current Treatment Options in Oncology,7,10.1007/s11864-012-0193-5,United States,Article,Rochester,0,Journal,2-s2.0-84865688671
Zhou C.,,Characterization of buried glands before and after radiofrequency ablation by using 3-dimensional optical coherence tomography (with videos),2012,Gastrointestinal Endoscopy,88,10.1016/j.gie.2012.02.003,United States,Article,Cambridge,0,Journal,2-s2.0-84862639146
Janarthanan S.,,Clostridium difficile-associated diarrhea and proton pump inhibitor therapy: A meta-analysis,2012,American Journal of Gastroenterology,322,10.1038/ajg.2012.179,United States,Review,Detroit,0,Journal,2-s2.0-84863726088
Desai T.,,The incidence of oesophageal adenocarcinoma in non-dysplastic Barrett's oesophagus: A meta-analysis,2012,Gut,326,10.1136/gutjnl-2011-300730,United States,Article,Royal Oak,0,Journal,2-s2.0-84861579225
Fischbach L.,,The association between Barrett's esophagus and Helicobacter pylori infection: A meta-analysis,2012,Helicobacter,63,10.1111/j.1523-5378.2011.00931.x,United States,Article,Fort Worth,0,Journal,2-s2.0-84860204739
Dunbar K.,,The risk of lymph-node metastases in patients with high-grade dysplasia or intramucosal carcinoma in Barrett's esophagus: A systematic review,2012,American Journal of Gastroenterology,149,10.1038/ajg.2012.78,United States,Review,Dallas,0,Journal,2-s2.0-84861888970
Winberg H.,,Risk factors and chemoprevention in Barrett's esophagus - An update,2012,Scandinavian Journal of Gastroenterology,23,10.3109/00365521.2012.667145,Sweden,Article,Stockholm,0,Journal,2-s2.0-84858645630
Quante M.,,Bile acid and inflammation activate gastric cardia stem cells in a mouse model of barrett-like metaplasia,2012,Cancer Cell,256,10.1016/j.ccr.2011.12.004,Germany;United States,Article,Munich;New York,1,Journal,2-s2.0-84862909168
Cook M.,,Cigarette smoking increases risk of Barrett's esophagus: An analysis of the barrett's and esophageal adenocarcinoma consortium,2012,Gastroenterology,102,10.1053/j.gastro.2011.12.049,United States,Article,Bethesda,1,Journal,2-s2.0-84859415429
Shaheen N.,,Upper endoscopy for gastroesophageal reflux disease: Best practice advice from the clinical guidelines committee of the american college of physicians,2012,Annals of Internal Medicine,108,10.7326/0003-4819-157-11-201212040-00008,United States,Review,Chapel Hill,0,Journal,2-s2.0-84870548608
Bavishi C.,,Systematic review: The use of proton pump inhibitors and increased susceptibility to enteric infection,2011,Alimentary Pharmacology and Therapeutics,262,10.1111/j.1365-2036.2011.04874.x,United States,Review,Houston,0,Journal,2-s2.0-81355160270
Gray N.,,Buried metaplasia after endoscopic ablation of barrett's esophagus: A systematic review,2011,American Journal of Gastroenterology,139,10.1038/ajg.2011.255,United States,Review,Dallas,0,Journal,2-s2.0-80655127761
Hvid-Jensen F.,,Incidence of adenocarcinoma among patients with Barrett's esophagus,2011,New England Journal of Medicine,861,10.1056/NEJMoa1103042,Denmark,Article,Aarhus,0,Journal,2-s2.0-80054010196
Coleman H.,,Increasing incidence of Barrett's oesophagus: A population-based study,2011,European Journal of Epidemiology,67,10.1007/s10654-011-9596-z,United Kingdom,Article,Belfast,0,Journal,2-s2.0-80054716837
Huo X.,,Deoxycholic acid causes DNA damage while inducing apoptotic resistance through NF-Îº{green}b activation in benign barrett's epithelial cells,2011,American Journal of Physiology - Gastrointestinal and Liver Physiology,68,10.1152/ajpgi.00092.2011,United States,Article,Dallas,0,Journal,2-s2.0-79960977948
Sarzynski E.,,Association between proton pump inhibitor use and anemia: A retrospective cohort study,2011,Digestive Diseases and Sciences,72,10.1007/s10620-011-1589-y,United States,Article,East Lansing,0,Journal,2-s2.0-79960963240
Bhat S.,,Risk of malignant progression in Barrett's Esophagus patients: Results from a large population-based study,2011,Journal of the National Cancer Institute,429,10.1093/jnci/djr203,United Kingdom,Article,Belfast,1,Journal,2-s2.0-79960249713
Vaccaro B.,,Detection of intestinal metaplasia after successful eradication of Barrett's esophagus with radiofrequency ablation,2011,Digestive Diseases and Sciences,84,10.1007/s10620-011-1680-4,United States,Article,New York,0,Journal,2-s2.0-79959721101
Sikkema M.,,Predictors for neoplastic progression in patients with Barrett's esophagus: A prospective cohort study,2011,American Journal of Gastroenterology,130,10.1038/ajg.2011.153,Netherlands;Netherlands,Article,Utrecht;Rotterdam,0,Journal,2-s2.0-79960069342
Wang X.,,Residual embryonic cells as precursors of a Barrett's-like metaplasia,2011,Cell,224,10.1016/j.cell.2011.05.026,United States,Article,Boston,1,Journal,2-s2.0-79959631111
Lagergren J.,,Influence of obesity on the risk of esophageal disorders,2011,Nature Reviews Gastroenterology and Hepatology,103,10.1038/nrgastro.2011.73,Sweden,Review,Stockholm,0,Journal,2-s2.0-79958145651
Leers J.,,The prevalence of lymph node metastases in patients with T1 esophageal adenocarcinoma: A retrospective review of esophagectomy specimens,2011,Annals of Surgery,154,10.1097/SLA.0b013e3181fbad42,,Review,,0,Journal,2-s2.0-79151472735
Rice T.,,Fate of the esophagogastric anastomosis,2011,Journal of Thoracic and Cardiovascular Surgery,8,10.1016/j.jtcvs.2010.12.022,United States,Article,Cleveland,1,Journal,2-s2.0-79952991449
El-Serag H.,,Routine polypectomy for colorectal polyps and ablation for barrett's esophagus are intellectually the same,2011,Gastroenterology,21,10.1053/j.gastro.2010.12.019,United States,Editorial,Houston,0,Journal,2-s2.0-79251555670
Quasdorff M.,,Recurrent hypomagnesemia with proton-pump inhibitor rechallenge,2011,Annals of Internal Medicine,22,10.7326/0003-4819-155-6-201109200-00022,Germany,Letter,Koln,0,Journal,2-s2.0-80052938041
Kastelein F.,,Nonsteroidal anti-inflammatory drugs and statins have chemopreventative effects in patients with Barrett's esophagus,2011,Gastroenterology,90,10.1053/j.gastro.2011.08.036,Netherlands,Article,Rotterdam,0,Journal,2-s2.0-81855167480
Wani S.,,Patients With Nondysplastic Barrett's Esophagus Have Low Risks for Developing Dysplasia or Esophageal Adenocarcinoma,2011,Clinical Gastroenterology and Hepatology,151,10.1016/j.cgh.2010.11.008,United States,Article,Kansas City,0,Journal,2-s2.0-79951689284
Spechler S.,,American gastroenterological association technical review on the management of Barrett's esophagus,2011,Gastroenterology,427,10.1053/j.gastro.2011.01.031,United States,Review,Dallas,0,Journal,2-s2.0-79952305740
,,American gastroenterological association medical position statement on the management of Barrett'S esophagus,2011,Gastroenterology,653,10.1053/j.gastro.2011.01.030,,Review,,0,Journal,2-s2.0-79952288119
Keszthelyi D.,,Proton pump inhibitor use is associated with an increased risk for microscopic colitis: A case-control study,2010,Alimentary Pharmacology and Therapeutics,76,10.1111/j.1365-2036.2010.04453.x,Netherlands,Article,Maastricht,0,Journal,2-s2.0-78649486172
Namasivayam V.,,Endoscopic mucosal resection in the management of esophageal neoplasia: Current status and future directions,2010,Clinical Gastroenterology and Hepatology,26,10.1016/j.cgh.2010.05.030,United States,Review,Rochester,0,Journal,2-s2.0-77956174465
Fleischer D.,,The case for endoscopic treatment of non-dysplastic and low-grade dysplastic barrett's esophagus,2010,Digestive Diseases and Sciences,58,10.1007/s10620-010-1218-1,United States,Article,Scottsdale,0,Journal,2-s2.0-77954426861
Curvers W.L.,,Low-grade dysplasia in barrett's esophagus: Overdiagnosed and underestimated,2010,American Journal of Gastroenterology,308,10.1038/ajg.2010.171,Netherlands;Netherlands,Review,Amsterdam;Amsterdam,0,Journal,2-s2.0-77954424898
Pohl H.,,Esophageal adenocarcinoma incidence: Are we reaching the peak?,2010,Cancer Epidemiology Biomarkers and Prevention,277,10.1158/1055-9965.EPI-10-0012,United States;United States,Article,White River Junction;Hanover,1,Journal,2-s2.0-77953307285
Zhang H.,,"In benign Barrett's epithelial cells, acid exposure generates reactive oxygen species that cause DNA double-strand breaks",2009,Cancer Research,60,10.1158/0008-5472.CAN-09-2518,United States,Article,Dallas,1,Journal,2-s2.0-71549166650
Kedika R.,,Potential anti-inflammatory effects of proton pump inhibitors: A review and discussion of the clinical implications,2009,Digestive Diseases and Sciences,193,10.1007/s10620-009-0951-9,United States;United States,Review,Dallas;Dallas,0,Journal,2-s2.0-70350212812
Riddell R.,,Definition of barrett's esophagus: Time for a rethinkis intestinal metaplasia dead,2009,American Journal of Gastroenterology,120,10.1038/ajg.2009.390,Canada,Review,Toronto,0,Journal,2-s2.0-70350491200
Merwat S.,,Might the use of acid-suppressive medications predispose to the development of eosinophilic esophagitis,2009,American Journal of Gastroenterology,71,10.1038/ajg.2009.87,United States,Note,Richardson,0,Journal,2-s2.0-68349158753
Crockett S.,,Health-Related Quality of Life in Patients With Barrett's Esophagus: A Systematic Review,2009,Clinical Gastroenterology and Hepatology,38,10.1016/j.cgh.2009.02.024,United States,Review,Chapel Hill,0,Journal,2-s2.0-66149181765
Shaheen N.J.,,Radiofrequency ablation in Barrett's esophagus with dysplasia,2009,New England Journal of Medicine,980,10.1056/NEJMoa0808145,United States;United States,Article,Chapel Hill;Chapel Hill,0,Journal,2-s2.0-66249084112
Wang A.,,Prevalence of complicated gastroesophageal reflux disease and Barrett's esophagus among racial groups in a multi-center consortium,2009,Digestive Diseases and Sciences,48,10.1007/s10620-009-0742-3,United States,Article,Portland,0,Journal,2-s2.0-63949087969
Shaheen N.,,Barrett's oesophagus,2009,The Lancet,237,10.1016/S0140-6736(09)60487-6,United States,Review,Chapel Hill,0,Journal,2-s2.0-61349116213
Rubenstein J.,,Effect of a prior endoscopy on outcomes of esophageal adenocarcinoma among United States veterans,2008,Gastrointestinal Endoscopy,73,10.1016/j.gie.2008.02.062,United States,Article,Ann Arbor,0,Journal,2-s2.0-54449098143
Pech O.,,Long-term results and risk factor analysis for recurrence after curative endoscopic therapy in 349 patients with high-grade intraepithelial neoplasia and mucosal adenocarcinoma in Barrett's oesophagus,2008,Gut,518,10.1136/gut.2007.142539,,Article,,0,Journal,2-s2.0-40949087789
Wang K.,,"Updated guidelines 2008 for the diagnosis, surveillance and therapy of Barrett's esophagus",2008,American Journal of Gastroenterology,915,10.1111/j.1572-0241.2008.01835.x,,Review,,0,Journal,2-s2.0-40949156279
Sarosi G.,,Bone marrow progenitor cells contribute to esophageal regeneration and metaplasia in a rat model of Barrett's esophagus,2008,Diseases of the Esophagus,120,10.1111/j.1442-2050.2007.00744.x,United States;United States;United States,Article,Dallas;Dallas;Gainesville,0,Journal,2-s2.0-38049187779
Spechler S.,,Screening and surveillance for Barrett's esophagus - An unresolved dilemma,2007,Nature Clinical Practice Gastroenterology and Hepatology,18,10.1038/ncpgasthep0876,United States,Review,Dallas,0,Journal,2-s2.0-34548476756
Sierra F.,,Systematic review: Proton pump inhibitor-associated acute interstitial nephritis,2007,Alimentary Pharmacology and Therapeutics,119,10.1111/j.1365-2036.2007.03407.x,Colombia;Colombia,Review,Bogota;Bogota,0,Journal,2-s2.0-34547442899
Chang E.,,The effect of antireflux surgery on esophageal carcinogenesis in patients with barrett esophagus: A systematic review,2007,Annals of Surgery,137,10.1097/01.sla.0000261459.10565.e9,United States,Review,Portland,0,Journal,2-s2.0-34347328236
El-Serag H.,,Time Trends of Gastroesophageal Reflux Disease: A Systematic Review,2007,Clinical Gastroenterology and Hepatology,285,10.1016/j.cgh.2006.09.016,United States,Review,Houston,0,Journal,2-s2.0-33846207511
El-Serag H.,,The prevalence of suspected Barrett's esophagus in children and adolescents: a multicenter endoscopic study,2006,Gastrointestinal Endoscopy,43,10.1016/j.gie.2006.03.010,United States,Article,Houston,0,Journal,2-s2.0-33749998721
Kuipers E.,,Proton pump inhibitors and Helicobacter pylori gastritis: Friends or foes?,2006,Basic and Clinical Pharmacology and Toxicology,10,10.1111/j.1742-7843.2006.pto_478.x,Netherlands,Short Survey,Rotterdam,0,Journal,2-s2.0-33747883757
Zhu H.,,Bacterial killing in gastric juice - Effect of pH and pepsin on Escherichia coli and Helicobacter pylori,2006,Journal of Medical Microbiology,65,10.1099/jmm.0.46611-0,United Kingdom,Article,Liverpool,1,Journal,2-s2.0-33748534513
Williams C.,,Review article: Proton pump inhibitors and bacterial overgrowth,2006,Alimentary Pharmacology and Therapeutics,168,10.1111/j.1365-2036.2006.02707.x,United Kingdom,Review,Glasgow,0,Journal,2-s2.0-33644892551
Ãberg S.,,Barrett esophagus: Risk factors for progression to dysplasia and adenocarcinoma,2005,Annals of Surgery,91,10.1097/01.sla.0000167864.46462.9f,Sweden,Article,Lund,0,Journal,2-s2.0-21444446170
Tran T.,,Fundoplication and the risk of esophageal cancer in gastroesophageal reflux disease: A veterans affairs cohort study,2005,American Journal of Gastroenterology,65,10.1111/j.1572-0241.2005.41007.x,,Article,,0,Journal,2-s2.0-19144370998
Spechler S.,,Dysplasia in Barrett's esophagus: Limitations of current management strategies,2005,American Journal of Gastroenterology,101,10.1111/j.1572-0241.2005.41201.x,United States;United States,Review,Dallas;Dallas,0,Journal,2-s2.0-17544366232
Shaheen N.,,Effect of a new diagnosis of Barrett's esophagus on insurance status,2005,American Journal of Gastroenterology,52,10.1111/j.1572-0241.2005.41422.x,United States,Article,Chapel Hill,0,Journal,2-s2.0-16844371860
Souza R.,,Concepts in the prevention of adenocarcinoma of the distal esophagus and proximal stomach,2005,Ca-A Cancer Journal for Clinicians,72,10.3322/canjclin.55.6.334,United States;United States,Review,Dallas;Dallas,1,Journal,2-s2.0-27944437003
Ronkainen J.,,Prevalence of Barrett's esophagus in the general population: An endoscopic study,2005,Gastroenterology,670,10.1053/j.gastro.2005.08.053,Sweden;Finland,Article,Stockholm;Ikaalinen,0,Journal,2-s2.0-28844461009
El-Serag H.,,Proton pump inhibitors are associated with reduced incidence of dysplasia in Barrett's esophagus,2004,American Journal of Gastroenterology,308,10.1111/j.1572-0241.2004.30228.x,,Article,,0,Journal,2-s2.0-7044232109
Hillman L.C.,,Proton-pump inhibitor therapy and the development of dysplasia in patients with Barrett's oesophagus,2004,Medical Journal of Australia,161,10.5694/j.1326-5377.2004.tb05991.x,Australia,Review,Canberra,0,Journal,2-s2.0-1942500137
Hur C.,,Cost-effectiveness of aspirin chemoprevention for Barrett's esophagus,2004,Journal of the National Cancer Institute,51,10.1093/jnci/djh039,United States,Article,Boston,1,Journal,2-s2.0-1342333710
Haigh C.,,Gastrin induces proliferation in Barrett's metaplasia through activation of the CCK<inf>2</inf> receptor,2003,Gastroenterology,131,10.1053/gast.2003.50091,United Kingdom,Article,Liverpool,0,Journal,2-s2.0-0037371890
Inadomi J.,,Screening and surveillance for Barrett esophagus in high-risk groups: A cost-utility analysis,2003,Annals of Internal Medicine,332,10.7326/0003-4819-138-3-200302040-00009,,Article,,0,Journal,2-s2.0-0037418145
Naylor G.,,Role of bacterial overgrowth in the stomach as an additional risk factor for gastritis.,2003,Canadian journal of gastroenterology = Journal canadien de gastroenterologie,19,10.1155/2003/350347,United Kingdom,Review,Leeds,1,Journal,2-s2.0-2142661667
Corey K.E.,,Does a Surgical Antireflux Procedure Decrease the Incidence of Esophageal Adenocarcinoma in Barrett's Esophagus? A Meta-Analysis,2003,American Journal of Gastroenterology,168,10.1111/j.1572-0241.2003.08702.x,United States,Article,Chapel Hill,0,Journal,2-s2.0-0344742266
Rex D.,,Screening for Barrett's Esophagus in Colonoscopy Patients with and without Heartburn,2003,Gastroenterology,369,10.1053/j.gastro.2003.09.030,United States;United States,Article,Indianapolis;Indianapolis,0,Journal,2-s2.0-0344628832
Corley D.,,Protective association of aspirin/NSAIDs and esophageal cancer: A systematic review and meta-analysis,2003,Gastroenterology,433,10.1053/gast.2003.50008,United States,Article,San Francisco,0,Journal,2-s2.0-0037219463
Sonnenberg A.,,Medical decision analysis of endoscopic surveillance of Barrett's oesophagus to prevent oesophageal adenocarcinoma,2002,Alimentary Pharmacology and Therapeutics,72,10.1046/j.1365-2036.2002.01146.x,United States;United States,Article,Albuquerque;Albuquerque,1,Journal,2-s2.0-0036161831
Iijima K.,,Dietary nitrate generates potentially mutagenic concentrations of nitric oxide at the gastroesophageal junction,2002,Gastroenterology,138,10.1053/gast.2002.32963,United Kingdom,Article,Glasgow,0,Journal,2-s2.0-0036237932
Dulai G.,,Preoperative prevalence of Barrett's esophagus in esophageal adenocarcinoma: A systematic review,2002,Gastroenterology,267,10.1053/gast.2002.30297,United States,Article,Los Angeles,0,Journal,2-s2.0-0036143976
Buttar N.S.,,Chemoprevention of esophageal adenocarcinoma by COX-2 inhibitors in an animal model of Barrett's esophagus,2002,Gastroenterology,326,10.1053/gast.2002.32371,United States,Article,Rochester,0,Journal,2-s2.0-0036204834
Corley D.A.,,Surveillance and survival in Barrett's adenocarcinomas: A population-based study,2002,Gastroenterology,417,10.1053/gast.2002.31879,United States;United States,Article,Berkeley;San Francisco,0,Journal,2-s2.0-0036179390
Spechler S.,,Long-term outcome of medical and surgical therapies for gastroesophageal reflux disease: Follow-up of a randomized controlled trial,2001,Journal of the American Medical Association,797,10.1001/jama.285.18.2331,United States,Article,Dallas,1,Journal,2-s2.0-0035832264
Ye W.,,Risk of adenocarcinomas of the esophagus and gastric cardia in patients with gastroesophageal reflux diseases and after antireflux surgery,2001,Gastroenterology,235,10.1053/gast.2001.29569,Sweden,Article,Stockholm,0,Journal,2-s2.0-0035214782
Souza R.,,Selective inhibition of cyclooxygenase-2 suppresses growth and induces apoptosis in human esophageal adenocarcinoma cells,2000,Cancer Research,295,,United States;United States,Article,Dallas;Dallas,0,Journal,2-s2.0-0034667497
Theisen J.,,Suppression of Gastric Acid Secretion in Patients with Gastroesophageal Reflux Disease Results in Gastric Bacterial Overgrowth and Deconjugation of Bile Acids,2000,Journal of Gastrointestinal Surgery,182,10.1016/S1091-255X(00)80032-3,United States,Article,Los Angeles,0,Journal,2-s2.0-0033630511
Shaheen N.,,Is there publication bias in the reporting of cancer risk in Barrett's esophagus?,2000,Gastroenterology,704,10.1053/gast.2000.9302,United States,Article,Chapel Hill,0,Journal,2-s2.0-0033866197
Provenzale D.,,Barrett's esophagus: A new look at surveillance based on emerging estimates of cancer risk,1999,American Journal of Gastroenterology,322,10.1111/j.1572-0241.1999.01276.x,United States,Article,Durham,0,Journal,2-s2.0-0033180014
Ouatu-Lascar R.,,Differentiation and proliferation in Barrett's esophagus and the effects of acid suppression,1999,Gastroenterology,332,10.1053/gast.1999.0029900327,United States,Article,Palo Alto,0,Journal,2-s2.0-0032782622
Sharma P.,,Short segment Barrett's esophagus - The need for standardization of the definition and of endoscopic criteria,1998,American Journal of Gastroenterology,247,10.1016/S0002-9270(98)00205-6,United States;United States,Review,Tucson;Tucson,0,Journal,2-s2.0-0032464684
Katz D.,,The development of dysplasia and adenocarcinoma during endoscopic surveillance of Barrett's esophagus,1998,American Journal of Gastroenterology,177,10.1111/j.1572-0241.1998.161_b.x,United States,Article,Madison,0,Journal,2-s2.0-0032056279
Drewitz D.,,The incidence of adenocarcinoma in Barrett's esophagus: A prospective study of 170 patients followed 4.8 years,1997,American Journal of Gastroenterology,478,,United States,Article,Tucson,0,Journal,2-s2.0-0031039244
Van Der Burgh A.,,Oesophageal cancer is an uncommon cause of death in patients with Barrett's oesophagus,1996,Gut,291,10.1136/gut.39.1.5,Netherlands,Article,Rotterdam,1,Journal,2-s2.0-0029980994
Parsonnet J.,,The incidence of Helicobacter pylori infection,1995,"Alimentary Pharmacology and Therapeutics, Supplement",321,,United States,Conference Paper,Stanford,0,Journal,2-s2.0-0029119213
Spechler S.,,Prevalence of metaplasia at the gastro-oesophageal junction,1994,The Lancet,514,10.1016/S0140-6736(94)90349-2,United States,Article,Boston,0,Journal,2-s2.0-0028036837
Lamberts R.,,"Long-term omeprazole therapy in peptic ulcer disease: Gastrin, endocrine cell growth, and gastritis",1993,Gastroenterology,307,10.1016/0016-5085(93)90344-C,Germany,Article,Gottingen,0,Journal,2-s2.0-0027162316
